Life Sciences Tools and Services
Company Overview of BioNano Genomics, Inc.
BioNano Genomics, Inc. operates as a genome mapping company. The company develops Irys, a flexible platform capable of providing single-molecule analysis of extremely long DNA. Its platform provides researchers and clinicians an organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. The company’s Irys system includes IrysPrep reagent kits that supplement readily available enzymes with other enzymes, dyes, and buffers needed to label non-amplified DNA for the Irys system; IrysChips for sample handling of precious or minute samples in a convenient 2-flowcell format; Irys Instrum...
9640 Towne Centre Drive
San Diego, CA 92121
Founded in 2003
Key Executives for BioNano Genomics, Inc.
Chief Executive Officer, President and Director
Founder and Chief Scientific Officer
Chief Financial Officer and Vice President of Finance
Vice President of Corporate Development
Compensation as of Fiscal Year 2015.
BioNano Genomics, Inc. Key Developments
BioNano Genomics, Inc. Presents at UBS Genomics 2.0 Summit, Aug-12-2015 06:30 PM
Aug 10 15
BioNano Genomics, Inc. Presents at UBS Genomics 2.0 Summit, Aug-12-2015 06:30 PM. Venue: The St. Regis Deer Valley, Park City, Utah, United States. Speakers: R. Erik Holmlin, Chief Executive Officer, President and Director.
BioNano Genomics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-12-2015 02:30 PM
Jul 13 15
BioNano Genomics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-12-2015 02:30 PM. Venue: Le Parker Meridian, 119 West 56th Street, New York, NY 10019, United States.
BioNano Genomics, Inc. Announces Addition of Gene Company as China Mainland and HK/Macau Distributor
Jul 9 15
BioNano Genomics, Inc. announced the selection of a new distributor, Gene Company, to further expand the distributorship of the Irys® System. In this agreement, Gene Company covers distribution for mainland China (excluding Shanghai), with exclusive rights in Hong Kong and Macau. With the signing of this agreement, BioNano Genomics continues to strengthen its presence as a global company, providing worldwide access to the Irys System for genomics researchers to complete genomes and study structural variation and complex genomic rearrangements.
Similar Private Companies By Industry
Recent Private Companies Transactions
September 9, 2014